Rituximab BS IV infusion 100mg “Pfizer” is a biosimilar of rituximab (genetical recombination), manufactured by Pfizer. This injectable drug (YJ code: 4291451A1028) is supplied as 100mg in 10mL per bottle, used to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and other autoimmune diseases.
Rituximab BS IV infusion 100mg “Pfizer”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →